Health
Why Might Cassava Succeed With Its Alzheimer’s Drug, When So Many Have Failed? – The Motley Fool
Alzheimer’s research has been hampered by apparently mistaken ideas about what causes the disease. Cassava has a new theory about…
Cassava Sciences(NASDAQ:SAVA) is like any other unprofitable biotech — it has a drug in clinical trials, and its investors are hoping the drug works so they can make a lot of money. What makes Cassava really interesting is that it’s zigging where Big Pharma…
Continue Reading
-
General20 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General18 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News18 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
Noosa News20 hours agoATO investigator found to have lied in fraud case